SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-19-018484
Filing Date
2019-09-16
Accepted
2019-09-16 16:30:18
Documents
4
Period of Report
2019-09-11
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K nby20190914_8k.htm 8-K 24159
2 EXHIBIT 99.1 ex_157885.htm EX-99.1 11605
3 a1.jpg GRAPHIC 23909
4 a2.jpg GRAPHIC 12371
  Complete submission text file 0001437749-19-018484.txt   76355
Mailing Address 2000 POWELL STREET, SUITE 1150 EMERYVILLE CA 94608
Business Address 2000 POWELL STREET, SUITE 1150 EMERYVILLE CA 94608 (510) 899-8800
NovaBay Pharmaceuticals, Inc. (Filer) CIK: 0001389545 (see all company filings)

IRS No.: 680454536 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33678 | Film No.: 191094970
SIC: 2834 Pharmaceutical Preparations